A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To investigate long-term efficacy and prognostic factors of half-dose photodynamic therapy (PDT) in chronic central serous chorioretinopathy (CSCR).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Ophthalmol.

Title: American journal of ophthalmology

Publisher: Elsevier BV

ISSN (Electronic): 1879-1891

ISSN (Print): 0002-9394

Publication date (Electronic): Oct 2016

Volume: 170

Affiliations

[1 ] Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, the Chinese University of Hong Kong, Kowloon, Hong Kong.

[2 ] Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, the Chinese University of Hong Kong, Kowloon, Hong Kong.

[3 ] Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, the Chinese University of Hong Kong, Kowloon, Hong Kong; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, the Chinese University of Hong Kong, Kowloon, Hong Kong. Electronic address: brelen.marten@googlemail.com.

Article

Publisher Item ID: S0002-9394(16)30372-5

DOI: 10.1016/j.ajo.2016.07.026

PubMed ID: 27519561

SO-VID: b5d47149-5b35-455c-82fa-efa5ffba9789

History

Data availability:

A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.

Read this article at

Abstract

Related collections

Long Covid Research Collection

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 37